[Control of the resistance of gram-negative bacilli to aminoglucosides. Results of a 3-year prospective study with the exclusive use of amikacin].
D000583:Amikacin / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D006090:Gram-Negative Bacteria / Q000187:drug effects; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives*; D008826:Microbial Sensitivity Tests; D011446:Prospective Studies
D007612:Kanamycin; D000583:Amikacin
Control de la resistencia de bacilos gram negativos a aminoglucosidos. Resultados de un estudio prospectivo a 3 años con el uso exclusivo de amikacina.